Sarah Holt

Sarah Holt is an accomplished professional in the field of translational science and drug discovery, currently serving as the Director of Translational Science at Artios Pharma Ltd since October 2020. Prior to this role, Sarah held various key positions, including Deputy Laboratory Head at the Cancer Research UK-AstraZeneca Antibody Alliance Lab and Senior Bioscientist in Drug Discovery at the CRUK Manchester Institute. Sarah's earlier experience includes post-doctoral roles in Discovery Medicine and Clinical and Experimental Pharmacology at AstraZeneca and the Paterson Institute for Cancer Research, respectively. Sarah completed a PhD in Cell Biology at The University of Manchester.